Nuzenio

Spyre Therapeutics Announces

Spyre Therapeutics Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Spyre Therapeutics Announces Launch Of Spy772 Program - TradingViewTradingView · Mon, 10 Aug 2026 13:50:31 GMTSpyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:27 GMTKvika banki hf.: Transaction in relation to a share buy-back programme - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:11 GMTSpyre Therapeutics, Inc. SEC Filing (Aug 7, 2026) - Stock TitanStock Titan · Fri, 07 Aug 2026 20:40:02 GMTSpyre Therapeutics Announces Grants of Inducement Awards - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 20:26:06 GMTSpyre Therapeutics (SYRE) CFO sells 7,500 shares after option exercise - Stock TitanStock Titan · Thu, 06 Aug 2026 02:18:24 GMTSpyre expects six Phase 2 trial readouts in 2026; cash totals $1.1B - Stock TitanStock Titan · Tue, 04 Aug 2026 20:02:00 GMT

Timeline

Mon, 10 Aug 2026 13:50:31 GMTSpyre Therapeutics Announces Launch Of Spy772 Program - TradingView
Mon, 10 Aug 2026 12:21:27 GMTSpyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa - The Manila Times
Mon, 10 Aug 2026 12:21:11 GMTKvika banki hf.: Transaction in relation to a share buy-back programme - The Manila Times
Fri, 07 Aug 2026 20:40:02 GMTSpyre Therapeutics, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Fri, 07 Aug 2026 20:26:06 GMTSpyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
Thu, 06 Aug 2026 02:18:24 GMTSpyre Therapeutics (SYRE) CFO sells 7,500 shares after option exercise - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Spyre Therapeutics Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.